| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/10/2013 | CN101684118B Use of tricyclic compounds as glycine transport inhibitors |
| 04/10/2013 | CN101605784B Aza-bridged-ring compound |
| 04/10/2013 | CN101585860B 4',5,6-trimethoxy scutellarin as well as preparation method and pharmaceutical composition thereof |
| 04/10/2013 | CN101575289B Method for separating chemical components of daphne genkwa twigs |
| 04/10/2013 | CN101502553B Rhizoma atractylodis total terpene alcohol solid dispersoid, medicament composition and preparation method thereof |
| 04/10/2013 | CN101454334B Macrolide derivatives |
| 04/10/2013 | CN101415730B Compositions and methods of use for antibodies of c-Met |
| 04/09/2013 | US8415476 Indazole having analgesic activity |
| 04/09/2013 | US8415362 Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 04/09/2013 | US8415355 Pyrrolopyrimidine compounds and their uses |
| 04/09/2013 | US8415326 Pharmaceutical composition comprising chito-oligomers |
| 04/09/2013 | US8414916 Chewable soft capsule |
| 04/09/2013 | US8414915 Dual action, inhaled formulations providing both an immediate and sustained release profile |
| 04/09/2013 | US8414894 Human antibodies that bind human TNFα and methods of using same |
| 04/09/2013 | CA2749172C Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 04/09/2013 | CA2451116C Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms |
| 04/09/2013 | CA2399219C Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase |
| 04/09/2013 | CA2383470C Inhibition of secretion from non-neuronal cells |
| 04/04/2013 | WO2013049617A1 Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound |
| 04/04/2013 | WO2013049332A1 Inhibitors of monoacylglycerol lipase and methods of their use |
| 04/04/2013 | WO2013049287A1 Crystalline hydrochloride salt of (1- (4 -fluorophenyl) - 1h - indol - 5 - yl) - (3- (4- (thiazole - 2 - carbonyl) piperazin- 1 - yl) az etidin- 1 -yl) methanone and its use in the treatment of pain and metabolic disorders |
| 04/04/2013 | WO2013049200A1 Methods of treating periodontal inflammation and periodontal bone loss |
| 04/04/2013 | WO2013049164A1 SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS |
| 04/04/2013 | WO2013048965A1 Methods for treatment of diseases |
| 04/04/2013 | WO2013047889A1 Pharmaceutical composition for treating autoimmune diseases |
| 04/04/2013 | WO2013047869A1 Pharmaceutical composition containing loxoprofen or salt thereof |
| 04/04/2013 | WO2013047844A1 Ngf aptamer and application thereof |
| 04/04/2013 | WO2013047752A1 Antigen-binding molecule for promoting loss of antigens |
| 04/04/2013 | WO2013047719A1 2-(pyridine-2-yl)pyrimidine-4-amine compound and salt thereof |
| 04/04/2013 | WO2013047373A1 Aqueous formulation containing chlorite |
| 04/04/2013 | WO2013045519A1 Derivatives of 6-substituted triazolopyridazines as rev-erb agonists |
| 04/04/2013 | WO2013045380A2 Pharmaceutically acceptable mglur5 positive allosteric modulators and their methods of identification |
| 04/04/2013 | WO2013045028A1 Benzyl piperidine compounds as lysophosphatidic acid (lpa) receptor antagonist |
| 04/04/2013 | WO2013044298A1 Antibodies against tl1a and uses thereof |
| 04/04/2013 | WO2013007361A8 Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 04/04/2013 | WO2013005698A9 Biological inorganic compound complex having reduced oxygen and high reducing ability |
| 04/04/2013 | WO2012178127A3 Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites |
| 04/04/2013 | WO2012177903A3 Methods of treating cognitive impairment |
| 04/04/2013 | WO2012177081A3 Pharmaceutical composition for preventing and treating inflammatory disease containing an ardisia tinctoria extract or a fraction thereof as an active ingredient |
| 04/04/2013 | WO2012174013A3 Treatment of cardiovascular disease, stroke, and inflammatory conditions |
| 04/04/2013 | WO2012173987A3 Methods of treatment using a bcat1 inhibitor |
| 04/04/2013 | US20130086701 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 04/04/2013 | US20130085461 Method for Pre-Debriding Treatment of Non-Viable Skin Tissue and Compositions and System Thereof |
| 04/04/2013 | US20130085175 Process for the preparation of sulfamide derivatives |
| 04/04/2013 | US20130085172 Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound |
| 04/04/2013 | US20130085171 Compounded transdermal pain management |
| 04/04/2013 | US20130085138 Selective NR2B Antagonists |
| 04/04/2013 | US20130084289 Treatment of multiple sclerosis |
| 04/04/2013 | CA2850549A1 Antibodies against tl1a and uses thereof |
| 04/04/2013 | CA2850346A1 Ngf aptamer and application thereof |
| 04/04/2013 | CA2850194A1 Antigen-binding molecule for promoting loss of antigens |
| 04/04/2013 | CA2849910A1 Antioxidant compositions for treatment of inflammation or oxidative damage |
| 04/04/2013 | CA2849820A1 Benzyl piperidine compounds as lysophosphatidic acid (lpa) receptor antagonist |
| 04/04/2013 | CA2849779A1 Crystalline hydrochloride salt of (1- (4 -fluorophenyl) - 1h - indol - 5 - yl) - (3- (4- (thiazole - 2 - carbonyl) piperazin-1 - yl) az etidin- 1 -yl) methanone and its use in the treatment of pain and metabolic disorders |
| 04/04/2013 | CA2849456A1 Methods for treatment of diseases |
| 04/04/2013 | CA2848518A1 Derivatives of 6-substituted triazolopyridazines as rev-erb agonists |
| 04/04/2013 | CA2848154A1 Novel heterocyclic derivatives and their uses |
| 04/04/2013 | CA2846200A1 Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound |
| 04/03/2013 | EP2574172A2 Materials and methods for treatment of inflammation |
| 04/03/2013 | CN202844162U Magnetic quadrupole pain relieving plaster |
| 04/03/2013 | CN103025758A IL-1 binding proteins |
| 04/03/2013 | CN103025725A Hetero ring compound |
| 04/03/2013 | CN103025387A Tamarind seed polysaccharide for use in the treatment of inflammatory diseases |
| 04/03/2013 | CN103025386A Tamarind seed polysaccharide for use in the treatment of microbial infections |
| 04/03/2013 | CN103025354A Treatment drug for autoimmune diseases and allergic diseases |
| 04/03/2013 | CN103025335A Corrosion current-generating metal particulates and use thereof |
| 04/03/2013 | CN103013997A MiRNA for restricting activity of hyaluronidase and application thereof |
| 04/03/2013 | CN103013743A Preparation method of broadleaf holly leaf healthcare wine |
| 04/03/2013 | CN103012597A OGP-CTx fusion protein for treating osteoporosis and relieving pain and nucleic acid encoding same |
| 04/03/2013 | CN103012590A Anti-CD20 monoclonal antibody, preparation method and application thereof |
| 04/03/2013 | CN103012555A Preparation method for new polypeptide having tissue protection activity, and application of new polypeptide in treatment |
| 04/03/2013 | CN103012554A Hydrocortisone-RGD polypeptide conjugate, and preparation method and application thereof |
| 04/03/2013 | CN103012553A Cortisone-RGD polypeptide conjugate, and preparation method and application thereof |
| 04/03/2013 | CN103012543A 3 alpha,11 alpha-dihydroxy-23-formyl-lupin-20(29)-alkene-28-acid with anti-inflammatory action and preparation method of 3 alpha,11 alpha-dihydroxy-23-formyl-lupin-20(29)-alkene-28-acid. |
| 04/03/2013 | CN103012537A Dammarane type triterpene compound and preparation method and application thereof |
| 04/03/2013 | CN103012523A Flavonoids separated from Qingkailing, and preparation method and application thereof |
| 04/03/2013 | CN103012421A Isoquinoline drug, its preparation and application |
| 04/03/2013 | CN103012407A N-[4-(1H-pyrazolo[3,4-b]pyrazine-6-yl)-phenyl]-sulfonamides and application of N-[4-(1H-pyrazolo[3,4-b]pyrazine-6-yl)-phenyl]-sulfonamides as medicines |
| 04/03/2013 | CN103012390A Indole derivatives as S1P1 receptor |
| 04/03/2013 | CN103012376A Amide derivatives |
| 04/03/2013 | CN103012374A Piperizinylpiperidine derivatives as chemokine receptor antagonists |
| 04/03/2013 | CN103012349A Crystal form C of 7-hydroxyisoflavone and preparation method thereof, and pharmaceutical composition and application thereof |
| 04/03/2013 | CN103012336A Water-soluble amino-acid ester derivative of andrographolide and dehydroandrographolide |
| 04/03/2013 | CN103012254A Pyridone derivatives for modulating stress-activated protein kinase system |
| 04/03/2013 | CN103012248A Synthesis of amino combretastatin derivative and application of amino combretastatin derivative as oral antitumour drug |
| 04/03/2013 | CN103012142A (E)-4-(3,5-dihydroxystyryl)-2-phenyl chloroacetate compound and preparation method thereof |
| 04/03/2013 | CN103012141A (E)-3-hydroxy-5-(hydroxystyryl)-2-phenyl chloroacetate compound and preparation method thereof |
| 04/03/2013 | CN103007270A Injection injected into acupoint Houhai to treat piglet diarrhea |
| 04/03/2013 | CN103007244A Traditional Chinese medicine composition for treating cervical vertebra and lumbar vertebra diseases |
| 04/03/2013 | CN103007220A Medicinal composition for treating cold of children |
| 04/03/2013 | CN103007213A Chinese medicinal composition for treating arthralgia |
| 04/03/2013 | CN103007184A Method for making health-care plaster and health-care plaster made by same |
| 04/03/2013 | CN103007144A Medicinal composition for treating bone traumas |
| 04/03/2013 | CN103007143A Gaultheria forrestii Diels medicinal liquor and preparation method thereof |
| 04/03/2013 | CN103007108A Traditional Chinese medicine for treatments of rheumatic arthritis, rheumatoid arthritis and hyperosteogeny |
| 04/03/2013 | CN103007103A Formula and preparation method of medicine used for treating pig high fever |
| 04/03/2013 | CN103007092A Formula of sciatica treatment traditional Chinese medicine |
| 04/03/2013 | CN103007058A Medicine for treating diabetes, hypertension and rheumatoid diseases and preparation method thereof |
| 04/03/2013 | CN103007051A Traditional Chinese medicine composition for treating heel pain caused by blood stasis |
| 04/03/2013 | CN103007017A Goiter and stasis removing compound medicine |